Bibliometric analysis of immune dysregulation and immunotherapy in mismatch repair-deficient colon cancer
Research on mismatch repair-deficient colon cancer is poised to enter a golden age in the coming years. This study not only provides insights into the directions and frontiers of mismatch repair-deficient colon cancer research but also highlights that the treatment of mismatch repair-deficient colon cancer benefits from a multidisciplinary approach. The comparison of different immune-assisted therapies will contribute to a more comprehensive understanding of the therapeutic landscape. Ultimately, large-scale and well-designed clinical trials are required to establish a recognized standard that can benefit more patients with mismatch repair-deficient colon cancer.
Authors
- Qianqian Ye (ORCID: https://orcid.org/0009-0005-2366-1359)
- Zubing Mei (ORCID: https://orcid.org/0000-0001-6823-7205)
- De Zheng (ORCID: https://orcid.org/0000-0003-2109-1792)
- Xin Jin (ORCID: https://orcid.org/0000-0002-3295-7179)
- Hao Wang (ORCID: https://orcid.org/0000-0002-1961-0787)
- Min Yang (ORCID: https://orcid.org/0000-0003-4781-2615)
- Qingming Wang (ORCID: https://orcid.org/0000-0003-0221-6801)
- Ye Ri Han (ORCID: https://orcid.org/0009-0005-2521-080X)
Institutions
- Shanghai University of Traditional Chinese Medicine (CN)
- Shuguang Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1007/s12672-025-03396-0
- Primary Topic
- Genetic factors in colorectal cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shanghai Municipal Health Commission
- Science and Technology Commission of Shanghai Municipality